U.S. markets closed

Bio-Techne Corporation (TECH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
486.75+5.48 (+1.14%)
At close: 4:00PM EDT
486.75 0.00 (0.00%)
After hours: 04:01PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Previous Close481.27
Open481.83
Bid484.94 x 800
Ask485.91 x 1100
Day's Range479.36 - 487.77
52 Week Range228.67 - 488.23
Volume304,749
Avg. Volume246,053
Market Cap18.931B
Beta (5Y Monthly)1.12
PE Ratio (TTM)105.98
EPS (TTM)4.59
Earnings DateAug 05, 2021
Forward Dividend & Yield1.28 (0.27%)
Ex-Dividend DateMay 14, 2021
1y Target Est457.22
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-9% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Bio-Techne's RNAscope™ Technology Aids in the Retrospective Tissue Diagnosis of COVID-19 in cases with no previous testing for SARS-CoV-2
    PR Newswire

    Bio-Techne's RNAscope™ Technology Aids in the Retrospective Tissue Diagnosis of COVID-19 in cases with no previous testing for SARS-CoV-2

    Bio-Techne Corporation (NASDAQ: TECH) today announced that scientists at the U.S. Centers for Disease Control and Prevention (CDC) recently highlighted the importance of fixed tissue analysis for retrospective diagnosis of SARS-CoV-2 infection and characterization of viral strains, particularly for fatal cases in which no previous testing for SARS-CoV-2 was performed.

  • Bio-Techne Announces 2021 Investor Day and Webcast
    PR Newswire

    Bio-Techne Announces 2021 Investor Day and Webcast

    Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host its 2021 Investor Day on Friday, September 10, 2021, starting at 9:00 a.m. EDT. The meeting will take place at the Lotte New York Palace Hotel, 455 Madison Avenue, New York City.

  • Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay
    PR Newswire

    Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay

    Bio-Techne Corporation (NASDAQ: TECH) and PROGEN today announced the launch of the Simple Plex™ Adeno-Associated Virus (AAV2) viral titer assay for AAV2 total capsid quantification. Bio-Techne, owner of the leading ProteinSimple branded protein analysis portfolio of products, and PROGEN will offer the Simple Plex AAV2 viral titer assay on Ella™ instruments, its multiplexing immunoassay system. Combining the efficiency and reproducibility of the established AAV2 ELISAs from PROGEN with the conven